Evidera
Sandra Milev has a strong background in the field of healthcare research and analysis. Sandra started their career at Brogan Inc. in 2007, where they worked as a Methodology & Research Analyst. Sandra'sresponsibilities included conducting methodological research, developing large datasets protocols, and performing various statistical analyses. In 2010, they joined IMS Health as a Consultant. After a year, they moved to CADTH, where they worked as a Health Economist. Sandra'srole involved critically appraising health economic evaluations submitted by drug manufacturers and designing and developing health economic models. In 2014, Sandra joined Evidera as a Senior Research Associate, and over the years, they progressed to roles such as Senior Research Scientist, Director, and Senior Director. Sandra'swork at Evidera focused on research and scientific leadership.
Sandra Milev has a Master of Science (MSc) degree in Systems Science from the University of Ottawa. Prior to that, they obtained a Bachelor of Science (BSc) degree in Theoretical Mathematics from the University Sts Cyril and Methodius in Skopje, Macedonia.
This person is not in the org chart
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.